Medtronic
 
 

Tachyarrhythmia
Management

EnTrust™ Single Chamber ICD

Patient-Centered Therapy

that promotes natural cardiac function1

Intrincis Single Chamber ICD
EnTrust
Model D154VRC

EnTrust D154VRC1
35J delivered
8 seconds BOL, 11.8 seconds ERI
10.7 years*
35cc, 68g
Programmable Active Can®

* 10.7 years — Conditions: 15% VVI at 60 ppm, 3 V, 0.4 ms, 500 ohms; pre-arrhythmia EGM storage off; biannual charges
11 years — Conditions: 15% VVI at 60 ppm, 2.5 V, 0.4 ms, 900 ohms; pre-arrhythmia EGM storage off; biannual charges

Shock Less2, 3, 4

Unique features to reduce appropriate and inappropriate shocks

ATP During Charging to reduce appropriate shocks2, 3

  • Reduce 3 out of 4 shocks2, 3 with proven PainFREE programming, with no delay to definitive therapy.1
  • Exclusive Advancement -- Nominally ON1

ATP During Charging automatically delivers ATP while the capacitor charges, offering PainFREE termination of Fast VTs in the VF Zone with No Delay to definitive therapy.1

Medtronic PainFREE RX II clinical conclusion: "compared to shocks, empirical ATP for FVT is highly effective, equally safe, and improves patient quality of life. It prevents painful shocks without any clinical difference in episode duration, arrhythmic syncope, acceleration, or sudden death."3

Request information on Medtronic PainFREE Therapy Clinical Results and Programming Tips.

Accurate Detection to reduce inappropriate shocks2


Wavelet™ Dynamic Discrimination

Wavelet is an electrogram morphology algorithm with simple on-off programming. It automatically compares the electrogram (EGM) morphology during high rate rhythms to a stored template of normal (baseline) rhythm.1

Accurate detection, therapy when needed
Wavelet delivers fewer inappropriate therapies for SVT (compared to EGM width)6 and has been shown to increase specificity without decreasing sensitivity.7

Robust, ongoing template quality monitoring 6, 7
Wavelet adapts to changes in electrogram morphology and updates it automatically to adapt to changes in the morphology of normal beats.1

Clinically Proven Shock Reduction

112 centers, 1122 patients, 2237 episodes4

  • Clinically proven in the largest worldwide single chamber discrimination study.
  • Substantially reduced inappropriate therapy 78.2%**
  • Maintained 99.2% sensitivity based on 100% spontaneous arrhythmias.

Complete Information for More Efficient Patient Care1, 5,

EXCLUSIVE Cardiac Compass® Trends provides 14 months of trended data to aid device and drug therapy management and manage disease progression.
EXCLUSIVE Histograms include information prior to and since last session for easy comparison.
NEW Detailed, easy-to-use, clinically oriented Episode Logs.
NEW Summary Parameter Screen saves time and reduces programming steps4

Total AT/AF Co-morbidity Management

EnTrust family of ICDs provides a suite of features for total AT/AF co-morbidity management, including diagnostics to detect when your patient develops AT/AF, and both termination and intervention therapies.

  • Reactive ATP offers more opportunities to terminate long AT episodes.
  • Patient activated cardioversion with the InCheck™ Patient Assistant
  • Cardiac Compass® Trends provides unique AF burden trending as well as V. rate during AT/AF (bpm)
  • Atrial Preference Pacing (APP)
  • Atrial Rate Stabilization (ARS)
  • Post-Mode Switch Overdrive Pacing (PMOP)

I'd like to learn more about the EnTrust Dual Chamber ICD.

** When episodes with rate and duration overrides are excluded.

References
  1. Medtronic EnTrust™ ICD Reference Manual.
  2. Medtronic EnTrust Implant Manual.
  3. Wathen MS, DeGroot PJ, Sweeney MO et al., for the PainFREE Rx II Investigators. Prospective randomized multicenter trial of empirical antitachycardia pacing versus shocks for spontaneous rapid ventricular tachycardia in patients with implantable cardioverter-defibrillators: pacing fast ventricular tachycardia reduces shock therapies (PainFREE Rx II) trial results. Circulation. Oct 2004; 110: 2591 - 2596.
  4. Klein GK, Manolis A,, Viskin S , et al. Clinical performance of Waveletú Dynamic VT/SVT Discrimination Algorithm in a worldwide single chamber ICD population. Circulation. Abstract #1650, Oct 2004; Vol. 110, No. 17.
  5. Medtronic Human Factors Report, 2003, data on file.
  6. ICD Discrimination from supraventricular tachycardia by a Wavelet-transform based morphology algorithm; Europace 1 (suppl): D33, July 2000.
  7. Swerdlow CD, Brown ML, Lurie K, et al. Discrimination of ventricular tachycardia from supraventricular tachycardia by a downloaded wavelet-transform algorithm: a paradigm for development of implantable cardioverter defibrillator detection algorithms. J Cardiovasc Electrophysiol. May 2002;13(5):432-441.PMID: 12030523.

Additional Information

  • Request information
    PainFREE™ Therapy
    clinical results and programming tips
  • Learn more about the EnTrust Dual Chamber ICD
  • Medtronic Connect
    Visit Medtronic Connect
    for the latest in online presentation tools and in-depth information.